Tuija Lundán

1.7k total citations
18 papers, 293 citations indexed

About

Tuija Lundán is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tuija Lundán has authored 18 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Tuija Lundán's work include Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Tuija Lundán is often cited by papers focused on Chronic Myeloid Leukemia Treatments (13 papers), Chronic Lymphocytic Leukemia Research (8 papers) and Lymphoma Diagnosis and Treatment (6 papers). Tuija Lundán collaborates with scholars based in Finland, Sweden and Norway. Tuija Lundán's co-authors include Kimmo Porkka, Sakari Knuutila, Erkki Elonen, Henrik Edgren, Satu Mustjoki, Kim Vettenranta, Marcelo L. Larramendy, Yan Aalto, Juhani Vilpo and Anna Ferrer and has published in prestigious journals such as Blood, Cancer Letters and British Journal of Haematology.

In The Last Decade

Tuija Lundán

17 papers receiving 284 citations

Peers

Countries citing papers authored by Tuija Lundán

Since Specialization

Citations

This map shows the geographic impact of Tuija Lundán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuija Lundán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuija Lundán more than expected).

Fields of papers citing papers by Tuija Lundán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tuija Lundán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuija Lundán. The network helps show where Tuija Lundán may publish in the future.

Co-authorship network of co-authors of Tuija Lundán

This figure shows the co-authorship network connecting the top 25 collaborators of Tuija Lundán. A scholar is included among the top collaborators of Tuija Lundán based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tuija Lundán. Tuija Lundán is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment 2018 ·Journal of Pediatric Hematology/Oncology ·(unknown), (unknown), (unknown), (unknown), (unknown), Tuija Lundán, Kimmo Porkka, Olli Lohi	3
2	ChimericNUP98–NSD1transcripts from the cryptic t(5;11)(q35.2;p15.4) in adult de novo acute myeloid leukemia 2017 ·Leukemia & lymphoma ·(unknown), Jesús M. López Martí, Ashwini Kumar, Mika Kontro, Henrik Edgren, Alun Parsons, Tuija Lundán, Maija Wolf, Kimmo Porkka, Caroline A. Heckman	6
3	Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma 2014 ·Blood Cancer Journal ·Raija Silvennoinen, Tuija Lundán, Veli Kairisto, T‐T. Pelliniemi, Matti Putkonen, Pekka Anttila, Virva Huotari, Pentti Mäntymaa, Sanna Siitonen, Lasse Uotila, (unknown), Vesa Juvonen, Tuomas Selander, Kari Remes	26
4	The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia 2014 ·Haematologica ·Hanna Rajala, Thomas L. Olson, Michael J. Clemente, Sonja Lagström, Pekka Ellonen, Tuija Lundán, David Hamm, (unknown), Jesús M. López Martí, Emma Andersson, Andrés Jerez, Kimmo Porkka, J. Maciejewski, Thomas P. Loughran, Satu Mustjoki	68
5	Novel Activating STAT5B Mutations As Drivers Of T-ALL 2013 ·Blood ·Mika Kontro, Heikki Kuusanmäki, Samuli Eldfors, Tea Pemovska, Hanna Rajala, Henrik Edgren, Pekka Ellonen, Sonja Lagström, Tuija Lundán, Olli Kallioniemi, Satu Mustjoki, Kimmo Porkka, Caroline A. Heckman	2
6	Imatinib and pegylated IFN‐α2b discontinuation in first‐line chronic myeloid leukemia patients following a major molecular response 2013 ·European Journal Of Haematology ·Perttu Koskenvesa, Anna Kreutzman, Peter Rohoň, (unknown), (unknown), (unknown), (unknown), Kari Remes, Tuija Lundán, Henrik Hjorth‐Hansen, Jukka Vakkila, Bengt Simonsson, Satu Mustjoki, Kimmo Porkka	11
7	BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations? 2011 ·Medical Oncology ·Franz Gruber, Tuija Lundán, Rasmus Goll, (unknown), Ingvild Mikkola, Ole Petter Rekvig, Sakari Knuutila, Kari Remes, Tobias Gedde‐Dahl, Kimmo Porkka, Henrik Hjorth‐Hansen	11
8	Molecular monitoring and mutation analysis of patients with advanced phase CML and Ph+ ALL receiving dasatinib 2010 ·European Journal Of Haematology ·Ulla Olsson‐Strömberg, (unknown), Tuija Lundán, (unknown), (unknown), Martin Höglund, Bengt Simonsson, Kimmo Porkka, Gisela Barbany	3
9	Comparison of bone marrow high mitotic index metaphase fluorescence in situ hybridization to peripheral blood and bone marrow real time quantitative polymerase chain reaction on the International Scale for detecting residual disease in chronic myeloid leukemia 2008 ·Haematologica ·Tuija Lundán, Vesa Juvonen, Martin Mueller, Satu Mustjoki, (unknown), Veli Kairisto, Andreas Hochhaus, Sakari Knuutila, Kimmo Porkka	10
10	Novel prognostic factors in chronic myeloid leukemia 2008 ·Työväentutkimus Vuosikirja ·Tuija Lundán	0
11	Imatinib Discontinuation Following a Major Molecular Response: Impact of Interferon Alpha and Leukemia Stem Cell Burden (The STOP Study). 2008 ·Blood ·Perttu Koskenvesa, Satu Mustjoki, (unknown), (unknown), Kari Remes, Tuija Lundán, Jukka Vakkila, Bengt Simonsson, Kimmo Porkka	4
12	Clonal Large Granular Lymphocyte (LGL) Expansion Associated with Dasatinib Therapy. 2007 ·Blood ·Satu Mustjoki, (unknown), Marja Ekblom, Auvo Rauhala, Marjatta Sinisalo, A. Almqvist, E. Koivunen, Tuija Lundán, Freja Ebeling, Perttu Koskenvesa, Henrik Hjorth‐Hansen, Petteri T. Arstila, Leif Stenke, Juan Luis Steegmann, Martin Höglund, Bengt Simonsson, Neil P. Shah, Ronald Paquette, Kimmo Porkka	7
13	Nordic CML Study Group Quality and Standardization Rounds for Quantitative RT-PCR of BCR-ABL To Facilitate Reporting on the International Scale. 2007 ·Blood ·Hans Boström, Tuija Lundán, Morten Andersen, Gisela Barbany, Thoas Fioretos, Irina Golovleva, Jon Jonasson, Vesa Juvonen, Mikael Lindlöf, (unknown), Niels Pallisgaard, Eeva‐Riitta Savolainen, Marie Schaffer, (unknown), Henrik Hjorth‐Hansen, Magnús K. Magnússon, (unknown), Kimmo Porkka, Bengt Simonsson, Veli Kairisto	1
14	Quantitative Analyses of BCR-ABL Mutations Associated with Imatinib Treatment in CML. 2005 ·Blood ·Franz Gruber, (unknown), (unknown), (unknown), Bjøŕn Skogen, Tobias Gedde‐Dahl, Tuija Lundán, Kimmo Porkka, Bengt Simonsson, Berit Markevärn, Hans Wadenvik, Leif Stenke	1
15	Childhood‐onset osteoarthritis, tall stature, and sensorineural hearing loss associated with Arg⁷⁵‐Cys mutation in procollagen type II gene (COL2A1) 2004 ·Arthritis Care & Research ·Tuija Löppönen, Jarmo Körkkö, Tuija Lundán, Ulpu Seppänen, Jaakko Ignatius, Helena Kääriäinen	32
16	Characterization and expression of the human WNT4; lack of associated germline mutations in high—to moderate—risk breast and ovarian cancer 2004 ·Cancer Letters ·Hellevi Peltoketo, Minna Allinen, Jaana Vuosku, Sonja T. Kujala, Tuija Lundán, (unknown), Robert Winqvist, Seppo Vainio	15
17	Clinical and practical value of metaphase fluorescent in situ hybridization in follow-up after allogeneic stem cell transplantation in chronic myeloid leukemia. 2004 ·PubMed ·Tuija Lundán, Liisa Volin, Erkki Elonen, K. Autio, Sakari Knuutila	4
18	Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma 2003 ·British Journal of Haematology ·Bálint Nagy, Tuija Lundán, Marcelo L. Larramendy, Yan Aalto, Ying Zhu, Tarja Niini, Henrik Edgren, Anna Ferrer, Juhani Vilpo, Erkki Elonen, Kim Vettenranta, Kaarle Franssila, Sakari Knuutila	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact